Neurotechnology Global Market Report 2024

The neurotechnology market size has grown rapidly in recent years. It will grow from $13.47 billion in 2023 to $15.28 billion in 2024 at a compound annual growth rate (CAGR) of 13.5%. The expansion observed during the historical period can be attributed to several factors, including a surge in research funding, an aging population, the prevalence of neurological disorders, supportive regulatory frameworks, and various government initiatives.

The neurotechnology market size is expected to see rapid growth in the next few years. It will grow to $25.66 billion in 2028 at a compound annual growth rate (CAGR) of 13.8%. The anticipated growth in the forecast period can be attributed to regulatory advancements, the intersection of genomics with neurological disorders, the integration of telemedicine in neurology, the adoption of precision medicine, and the development of closed-loop systems. Key trends expected in the forecast period encompass advancements in neuroinformatics, interventions related to neuroplasticity, initiatives in brain mapping, the implementation of remote monitoring solutions, and the utilization of non-invasive brain stimulation techniques.

The anticipated increase in the prevalence of neurological conditions is set to drive the growth of the neurotechnology market in the coming years. Neurological conditions encompass various disorders or diseases affecting the brain, including Alzheimer's disease, Parkinson's disease, epilepsy, and migraine. Neurotechnology is playing a crucial role in diagnosing and treating these conditions through methods such as brain imaging, neurostimulation, neurofeedback, and brain-computer interfaces. For example, as of January 2022, the American Heart Association Inc. projected that Alzheimer's disease and related dementias would impact approximately 9.3 million people in the United States by 2060. Additionally, according to the World Health Organization (WHO) in February 2023, an estimated 5 million people worldwide are expected to be diagnosed with epilepsy annually. Therefore, the increasing prevalence of neurological conditions is a driving force behind the growth of the neurotechnology market.

The upward trajectory of healthcare expenditure is expected to fuel the expansion of the neurotechnology market in the future. Healthcare expenditure, representing the total spending on healthcare-related goods and services within a healthcare system or economy, supports the growth of neurotechnology. This financial support facilitates research, provides access to advanced equipment, promotes education and training, supports clinical trials, ensures regulatory oversight, and makes innovative treatments more accessible to patients requiring neurological care. In November 2022, the Canadian Institute for Health Information reported that healthcare expenditure increased to 0.8%, reaching $331 billion in 2022, following a 7.6% increase in 2021. Therefore, the rising healthcare expenditure is a key driver propelling the growth of the neurotechnology market.

Technological advancements represent a significant trend gaining momentum in the neurotechnology market, with companies adopting innovative technologies to maintain their market positions. For instance, in November 2022, Blackrock Neurotech, a biotechnology company based in the United States, introduced Neuralace, a next-generation technology in neurotechnology. Neuralace, resembling a lace thinner than an eyelash, can cover large areas of the brain's surface. Designed as an ultra-high channel count, flexible electrode, Neuralace provides insights into the technology powering future brain-computer interfaces (BCIs). The system assists patients in regaining tactile function, limb and prosthetic movement, and the ability to control digital devices.

Major companies in the neurotechnology sector are engaging in partnerships to gain a competitive edge. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. For example, in June 2021, CorTec, a Germany-based neurotechnology company, formed a strategic partnership with Blackrock Neurotech, a U.S.-based biotechnology company specializing in brain-computer interface (BCI) systems. This collaboration aims to expedite access to researchers, open new markets, and broaden applications in the implantable neurotechnology markets.

In April 2022, Blackrock Neurotech, a U.S.-based biotechnology company, acquired Mindx Corporation for an undisclosed amount. This acquisition expands Blackrock's software portfolio and positions the company to offer integrated BCI products with cutting-edge features, enhancing its ability to provide a full-stack solution to customers. Mindx Corporation, based in the United States, is known for developing a neuron technology framework for use in spatial computing applications.

Major companies operating in the neurotechnology market report are General Electric, Medtronic PLC, Koninklijke Philips N.V., Toshiba Medical Systems Corporation, Shimadzu Corporation, EndoStim Inc., Elekta AB, Tristan Technologies Inc., Natus Medical Incorporated, Abbott, Boston Scientific Corporation, Cleveland Medical Devices Inc., Cogentix Medical Inc., Nihon Kohden Corporation, LivaNova PLC, Siemens Healthcare Private Limited, Hitachi Medical Corporation, Cochlear Limited, Advanced Bionics AG (Sonova), NeuroPace Inc., NeuroSigma Inc., NeuroMetrix Inc., NeuroSky Inc., NeuroVigil Inc., NeuroPheresis, Neurotech Pharmaceuticals Inc., Neurotech International Limited, NeurotechEU, Neurotech Solutions, Neurotech Reports, Neurotech Research Development.

North America was the largest region in the neurotechnology market in 2023. Europe is expected to be the fastest-growing region in the neurotechnology market report during the forecast period. The regions covered in the neurotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary neurotechnology applications include addressing conditions such as cognitive disorders, pain treatment, urinary and fecal incontinence, epilepsy, Parkinson's disease, hearing conditions, sleep disorders, depression, and various others. Cognitive disorders signify a significant decline in an individual's cognitive function to an extent that, without treatment, regular social activities become challenging. The diverse types of neurotechnology include imaging modalities, neurostimulation, cranial surface measurement, neurological implants, and others. These technologies find application in ambulatory surgical centers, hospitals, homecare facilities, and other medical settings.

The neurotechnology market research report is one of a series of new reports that provides neurotechnology market statistics, including neurotechnology industry global market size, regional shares, competitors with a neurotechnology market share, detailed neurotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the neurotechnology industry. This neurotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.